Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical API, chemical medicines, proprietary Chinese medicines, and nuclide drugs products in China. It offers heparin, chondroitin sulphate, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C for use in the therapeutic areas of cardiovascular, oncology, urology, orthopedics, and other therapeutic areas. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.
Yantai Dongcheng Pharmaceutical Dividend Announcement
• Yantai Dongcheng Pharmaceutical announced a annually dividend of ¥0.12 per ordinary share which will be made payable on 2024-06-24. Ex dividend date: 2024-06-24
• Yantai Dongcheng Pharmaceutical annual dividend for 2024 was ¥0.12
• Yantai Dongcheng Pharmaceutical annual dividend for 2023 was ¥0.15
• Yantai Dongcheng Pharmaceutical's trailing twelve-month (TTM) dividend yield is 0.94%
• Yantai Dongcheng Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 281.76%
• Yantai Dongcheng Pharmaceutical's dividend growth over the last five years (2018-2023) was 40.91% year
• Yantai Dongcheng Pharmaceutical's dividend growth over the last ten years (2013-2023) was -4.98% year
Yantai Dongcheng Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-24 | ¥0.12 | annually | 2024-06-24 |
2023-07-10 | ¥0.15 | annually | 2023-07-10 |
2022-06-09 | ¥0.15 | annually | 2022-06-09 |
2021-06-04 | ¥0.25 | annually | 2021-06-04 |
2020-05-27 | ¥0.25 | annually | 2020-05-27 |
2019-04-24 | ¥0.05 | annually | 2019-04-24 |
2018-05-24 | ¥0.03 | annually | 2018-05-24 |
2017-06-16 | ¥0.04 | annually | 2017-06-16 |
2016-05-20 | ¥0.11 | annually | |
2015-05-15 | ¥0.15 | annually | |
2014-07-15 | ¥0.13 | annually | |
2013-07-01 | ¥0.25 | annually |
Yantai Dongcheng Pharmaceutical Dividend per year
Yantai Dongcheng Pharmaceutical Dividend growth
Yantai Dongcheng Pharmaceutical Dividend Yield
Yantai Dongcheng Pharmaceutical current trailing twelve-month (TTM) dividend yield is 0.94%. Interested in purchasing Yantai Dongcheng Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Yantai Dongcheng Pharmaceutical Financial Ratios
Yantai Dongcheng Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Yantai Dongcheng Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Yantai Dongcheng Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Yantai Dongcheng Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Yantai Dongcheng Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Yantai Dongcheng Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Yantai Dongcheng Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Yantai Dongcheng Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Yantai Dongcheng Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Yantai Dongcheng Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Yantai Dongcheng Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Yantai Dongcheng Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.